260 related articles for article (PubMed ID: 34617633)
21. Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study.
Nishikawa N; Murata M; Hatano T; Mukai Y; Saitoh Y; Sakamoto T; Hanakawa T; Kamei Y; Tachimori H; Hatano K; Matsuda H; Taruno Y; Sawamoto N; Kajiyama Y; Ikenaka K; Kawabata K; Nakamura T; Iwaki H; Kadotani H; Sumi Y; Inoue Y; Hayashi T; Ikeuchi T; Shimo Y; Mochizuki H; Watanabe H; Hattori N; Takahashi Y; Takahashi R;
Parkinsonism Relat Disord; 2022 Oct; 103():129-135. PubMed ID: 36113390
[TBL] [Abstract][Full Text] [Related]
22. Detection of α-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder.
Zheng Y; Yu Z; Cai H; Kou W; Yang C; Li S; Zhang N; Feng T
Mov Disord; 2024 May; ():. PubMed ID: 38715177
[TBL] [Abstract][Full Text] [Related]
23. Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
Vilas D; Iranzo A; Tolosa E; Aldecoa I; Berenguer J; Vilaseca I; Martí C; Serradell M; Lomeña F; Alós L; Gaig C; Santamaria J; Gelpi E
Lancet Neurol; 2016 Jun; 15(7):708-718. PubMed ID: 27039162
[TBL] [Abstract][Full Text] [Related]
24. Rapid eye movement sleep behavior disorder: a narrative review from a technological perspective.
Gnarra O; Wulf MA; Schäfer C; Nef T; Bassetti CLA
Sleep; 2023 Jun; 46(6):. PubMed ID: 36789541
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies.
Rahayel S; Tremblay C; Vo A; Misic B; Lehéricy S; Arnulf I; Vidailhet M; Corvol JC; ; Gagnon JF; Postuma RB; Montplaisir J; Lewis S; Matar E; Ehgoetz Martens K; Borghammer P; Knudsen K; Hansen AK; Monchi O; Gan-Or Z; Dagher A;
Brain; 2023 Aug; 146(8):3301-3318. PubMed ID: 36826230
[TBL] [Abstract][Full Text] [Related]
26. Classifying Idiopathic Rapid Eye Movement Sleep Behavior Disorder, Controls, and Mild Parkinson's Disease Using Gait Parameters.
Cochen De Cock V; Dotov D; Lacombe S; Picot MC; Galtier F; Driss V; Giovanni C; Geny C; Abril B; Damm L; Janaqi S
Mov Disord; 2022 Apr; 37(4):842-846. PubMed ID: 35040193
[TBL] [Abstract][Full Text] [Related]
27. Brain cholinergic alterations in idiopathic REM sleep behaviour disorder: a PET imaging study with
Bedard MA; Aghourian M; Legault-Denis C; Postuma RB; Soucy JP; Gagnon JF; Pelletier A; Montplaisir J
Sleep Med; 2019 Jun; 58():35-41. PubMed ID: 31078078
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal Changes in Isolated Rapid Eye Movement Sleep Behavior Disorder-Related Metabolic Pattern Expression.
Kim R; Lee JY; Kim YK; Kim H; Yoon EJ; Shin JH; Yoo D; Nam H; Jeon B
Mov Disord; 2021 Aug; 36(8):1889-1898. PubMed ID: 33788284
[TBL] [Abstract][Full Text] [Related]
29. Disruption of Brainstem Structural Connectivity in REM Sleep Behavior Disorder Using 7 Tesla Magnetic Resonance Imaging.
García-Gomar MG; Videnovic A; Singh K; Stauder M; Lewis LD; Wald LL; Rosen BR; Bianciardi M
Mov Disord; 2022 Apr; 37(4):847-853. PubMed ID: 34964520
[TBL] [Abstract][Full Text] [Related]
30. Electroencephalogram slowing predicts neurodegeneration in rapid eye movement sleep behavior disorder.
Rodrigues Brazète J; Gagnon JF; Postuma RB; Bertrand JA; Petit D; Montplaisir J
Neurobiol Aging; 2016 Jan; 37():74-81. PubMed ID: 26545633
[TBL] [Abstract][Full Text] [Related]
31. Nocturnal eye movements in patients with idiopathic rapid eye movement sleep behaviour disorder and patients with Parkinson's disease.
Christensen JAE; Cesari M; Pizza F; Antelmi E; Frandsen RAV; Plazzi G; Jennum P
J Sleep Res; 2021 Jun; 30(3):e13125. PubMed ID: 32860309
[TBL] [Abstract][Full Text] [Related]
32. Electroencephalogram slowing in rapid eye movement sleep behavior disorder is associated with mild cognitive impairment.
Rodrigues Brazète J; Montplaisir J; Petit D; Postuma RB; Bertrand JA; Génier Marchand D; Gagnon JF
Sleep Med; 2013 Nov; 14(11):1059-63. PubMed ID: 24095264
[TBL] [Abstract][Full Text] [Related]
33. Brain olfactory-related atrophy in isolated rapid eye movement sleep behavior disorder.
Woo KA; Kim H; Yoon EJ; Shin JH; Nam H; Jeon B; Kim YK; Lee JY
Ann Clin Transl Neurol; 2023 Dec; 10(12):2192-2207. PubMed ID: 37743764
[TBL] [Abstract][Full Text] [Related]
34. Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern.
Janzen A; Kogan RV; Meles SK; Sittig E; Renken RJ; Geibl FF; Booij J; Stormezand G; Luster M; Mayer G; Leenders KL; Oertel WH
Mov Disord; 2022 Mar; 37(3):624-629. PubMed ID: 34796976
[TBL] [Abstract][Full Text] [Related]
35. Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder.
Iranzo A; Mammana A; Muñoz-Lopetegi A; Dellavalle S; Mayà G; Rossi M; Serradell M; Baiardi S; Arqueros A; Quadalti C; Perissinotti A; Ruggeri E; Cano JS; Gaig C; Parchi P
Neurology; 2023 May; 100(18):e1944-e1954. PubMed ID: 36931726
[TBL] [Abstract][Full Text] [Related]
36. Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder.
Shin JH; Lee JY; Kim YK; Yoon EJ; Kim H; Nam H; Jeon B
Neurology; 2021 Jul; 97(4):e378-e388. PubMed ID: 34011571
[TBL] [Abstract][Full Text] [Related]
37. Predictors of Conversion to α-Synucleinopathy Diseases in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
Ye G; Li Y; Zhou L; Zhang Y; Zhu L; Zhao A; Kang W; Liu J
J Parkinsons Dis; 2020; 10(4):1443-1455. PubMed ID: 32986685
[TBL] [Abstract][Full Text] [Related]
38. Increased Free Water in the Putamen in Idiopathic REM Sleep Behavior Disorder.
Zhang D; Zhou L; Yao J; Shi Y; He H; Wei H; Tong Q; Liu J; Wu T
Mov Disord; 2023 Sep; 38(9):1645-1654. PubMed ID: 37342973
[TBL] [Abstract][Full Text] [Related]
39. Correlations with REM sleep behavior disorder severity in isolated rapid eye movement sleep behavior disorders patients.
Kim SJ; Chung EJ; Ji KH; Kang MR; Hong JY; Lee S; Park JS; Oh JS; Kim JS; Kang SY
Int J Neurosci; 2023 Dec; 133(8):918-924. PubMed ID: 34913812
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of iron overload in nigrosome 1 via quantitative susceptibility mapping as a progression biomarker in prodromal stages of synucleinopathies.
Lancione M; Donatelli G; Del Prete E; Campese N; Frosini D; Cencini M; Costagli M; Biagi L; Lucchi G; Tosetti M; Godani M; Arnaldi D; Terzaghi M; Provini F; Pacchetti C; Cortelli P; Bonanni E; Ceravolo R; Cosottini M
Neuroimage; 2022 Oct; 260():119454. PubMed ID: 35810938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
